SCMR Membership Required To View the Lectures
Day 1 – Invited Lectures
To Set-up a Hybrid Imaging Lab: Motivation and Challenges
By Pamela Woodard – Mallinckrodt Institute of Radiology
PET-MR: Potential Clinical and Research Applications
By Jean-Paul Vallee – Hopitaux Universitaires de Geneve
CT: Current Role in Management of CAD
By Christian Loewe – University of Vienna
Echocardiographical Scenarios That Need Complementary Methods
By Katherine Wu – Johns Hopkins Medicine
Novel Devices for Interventional MRI
By Charles Dumoulin – Children’s Hospital Medical Center Cincinnati
MRI Guided EP: Procedure Guidance
By Matthias Gutberlet – University Leipzig/Heart Center Leipzig
MRI Guided Right Heart Catheterization: Clinical Experience
By Kanishka Ratnayaka – NHLBI
MRI Guided EP: Planning and Assessment
By Graham Wright – Sunnybrook Health Sciences Centre
CMR Perfusion for Prognosis
By Rory Hachamovitch – Cleveland Clinic
Perfusion vs. Oxygenation vs. Metabolism – Competitive or Complimentary
By Stefan Neubauer – University of Oxford
Overview: CMR vs. Other Perfusion Modalities
By Sven Plein – University of Leeds
CMR Perfusion for Assessment of Microvascular Disease
By Amedeo Chiribiri – King’s College London
Impact of Fat for Differentiation and Risk Stratification
By Hildo Lamb – Leiden University Medical Center
Learning Lessons from the Brain: Human Connectome – Connected to the Heart
By Kamil Ugurbil – University of Minnesota
New Techniques: Diffusion from Dream to Earth
By Dudley Pennell – Royal Brompton Hospital
Coronary Wall: Is Thickness the Holy Grail?
By Michael McConnell – Stanford University
Peripheral Lumen: The Promise of Non-contrast Methods
By James Carr – Northwestern University
Coronary Imaging in 2013
By Warren Manning – Beth Israel Deaconess Medical Center
The Aortic and Carotid Lumen: Contrast is Key
By Jens Bremerich – University Hospital Basel
Multi-spectral Imaging of the Non-coronary Wall
By Chun Yuan – University of Washington
Day 2 – Invited lectures
Cutting Edge CMR in Adult Fontan Patients – New Insights, New Tools
By Andrew Taylor – UCL Institute of Cardiovascular Science
The Fate of the Systemic RV After Atrial Switch
By Tal Geva – Children’s Hospital Boston
Aortic Coarctation in the Adult – New Light on an Old Problem
By Gerald Greil – King’s College London
Risk Stratification in Aortic Root Dilatation – Beyond Diameters?
By Albert de Roos, – Leiden University Medical Center
Functional CMR in the Newborn Infant
By Alan Groves, – Imperial College London
Ventricular Interaction and Regional Wall Motion Assessment by CMR
By Mark Fogel – Children’s Hospital of Philadelphia
Fetomaternal Circulation by CMR
By Ulrike Wedegärtner – University Medical Center Hamburg-Eppendorf
4D Flow – What Is It Good for in Congenital Heart Disease
By Tino Ebbers – Linköping University
First-pass Pulmonary Perfusion in Pediatric Cardiovascular Disease
By Rajesh Krishnamurthy – Texas Children’s Hospital
Left Ventricular Hypertrophy – Differentiation of the Underlying Cause – Only Amyloidosis?
By Alicia Maciera – ERESA Grupo Medico
Large Vessel Vasculitis – Lumen and Vessel Wall
By Sophie Mavrogeni – RCI Hellas SA
Functional CMR for the Assessment of Regional Myocardial Tissue Mechanics in Non-ischemic Heart Disease
By Michael Markl – Northwestern University
Rheumatologic Disorders – Myocardial Injury in Preserved Ejection Fraction
By Amit Patel – University of Chicago
Changes in Practice after 2008 Guidelines
By Eike Nagel – King’s College London
What are the New High Throughput Techniques We Can Use Clinically and Their Limitations
By Marcelo Nacif – Lausanne University
The Usefulness of Disease Specific Protocols
By Scott Flamm – Cleveland Clinic
Optimizing CMR Studies in Very Sick Patients
By Victor Ferrari – University of Pennsylvania
Post-processing: From T1 to ECV
By Martin Ugander – Karolinska Institute
Clinical Applications of Contrast-enhanced T1/ECV Mapping
By Andrew Flett – The Heart Hospital London
T1 Mapping in the Heart
By Peter Kellman – NHLBI
Clinical Applications of Native T1 Mapping
By Erica Dall’Armellina – University of Oxford
Day 3 – Invited lectures
CMR: What is Unique and What Can Change Clinical Reality Today? CMR Beyond Beauty
By Frank Rademakers – University Hospitals Leuven
Debate – T2 is Mandatory to Differentiate a Reversible Injury Pro
By Matthias Friedrich – CMR Centre at the Montreal Heart Institute
Late Breaking News – CMR from Mice to Men
By Andrew Arai – NHLBI
Non-ischemic Heart Failure: Can CMR Add to Current Clinical Decision Making Regarding Device Therapy?
By Francisco Leyva – Queen Elizabeth Hospital
Hypertrophic Cardiomyopathy: When and How Can CMR Improve Patient Management Currently?
By Christopher Kramer – University of Virginia
From Diagnosis and Risk Stratification with CMR to Improved Patient Management and Outcome?
By Steffen Petersen – Barts and The London
Iron Overload: Impact of CMR on Patient Management and Outcome
By Dudley Pennell – Royal Brompton Hospital